| Dept Of State Hospitals - Napa | |
| 2100 Napa Vallejo Highway, Napa, California 94558 | |
| (707) 253-5000 | |
| Not Available |
| Name | Dept Of State Hospitals - Napa |
|---|---|
| Type | Psychiatric Hospital |
| Location | 2100 Napa Vallejo Highway, Napa, California |
| Ownership | Government - State |
| Emergency Services | No |
| Medicare ID (CCN) | 054122 |
| NPI Number | 1194170092 |
| Organization Name | NSH |
| Address | 2100 Napa Vallejo Hwy, Napa, CA 94558 |
| Hospital Type | Psychiatric Hospital |
| Phone Number | 707-253-5264 |
News Archive
Educating people with diabetes in a primary-care setting with sustained, comprehensive intervention resulted in significant improvement in disease management and overall health, according to a study published in the current issue of Diabetes Care, a journal of the American Diabetes Association (ADA).
Roche Diabetes Care, makers of ACCU-CHEK products and services, has launched dedicated Facebook and Twitter accounts to promote diabetes education, awareness and advocacy.
Emergent BioSolutions Inc. announced today that it has closed on its acquisition of Bracco Diagnostics Inc.'s Healthcare Protective Products Division. This acquisition, which includes the RSDL (decontamination lotion) product that is cleared for marketing by the U.S. Food and Drug Administration for removal or neutralization of chemical warfare agents from the skin, diversifies and broadens Emergent's biodefense franchise into the chemical countermeasure market.
PharmaMar SA today announced that a registration trial in relapsed/refractory multiple myeloma patients has been initiated with Aplidin(R) (plitidepsin) in combination with dexamethasone versus dexamethasone alone.
› Verified 6 days ago
| NPI Number | 1326098161 |
| Organization Name | DEPARTMENT OF STATE HOSPITALS |
| Doing Business As | DEPARTMENT OF STATE HOSPITALS - NAPA |
| Address | 2100 Napa Vallejo Hwy, Napa, CA 94558 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 707-253-5000 |
News Archive
Educating people with diabetes in a primary-care setting with sustained, comprehensive intervention resulted in significant improvement in disease management and overall health, according to a study published in the current issue of Diabetes Care, a journal of the American Diabetes Association (ADA).
Roche Diabetes Care, makers of ACCU-CHEK products and services, has launched dedicated Facebook and Twitter accounts to promote diabetes education, awareness and advocacy.
Emergent BioSolutions Inc. announced today that it has closed on its acquisition of Bracco Diagnostics Inc.'s Healthcare Protective Products Division. This acquisition, which includes the RSDL (decontamination lotion) product that is cleared for marketing by the U.S. Food and Drug Administration for removal or neutralization of chemical warfare agents from the skin, diversifies and broadens Emergent's biodefense franchise into the chemical countermeasure market.
PharmaMar SA today announced that a registration trial in relapsed/refractory multiple myeloma patients has been initiated with Aplidin(R) (plitidepsin) in combination with dexamethasone versus dexamethasone alone.
› Verified 6 days ago
| NPI Number | 1427597228 |
| Organization Name | NAPA STATE HOSPITALS |
| Address | 2100 Napa Vallejo Hwy, Napa, CA 94558 |
| Hospital Type | Psychiatric Hospital |
| Phone Number | 707-253-5000 |
News Archive
Educating people with diabetes in a primary-care setting with sustained, comprehensive intervention resulted in significant improvement in disease management and overall health, according to a study published in the current issue of Diabetes Care, a journal of the American Diabetes Association (ADA).
Roche Diabetes Care, makers of ACCU-CHEK products and services, has launched dedicated Facebook and Twitter accounts to promote diabetes education, awareness and advocacy.
Emergent BioSolutions Inc. announced today that it has closed on its acquisition of Bracco Diagnostics Inc.'s Healthcare Protective Products Division. This acquisition, which includes the RSDL (decontamination lotion) product that is cleared for marketing by the U.S. Food and Drug Administration for removal or neutralization of chemical warfare agents from the skin, diversifies and broadens Emergent's biodefense franchise into the chemical countermeasure market.
PharmaMar SA today announced that a registration trial in relapsed/refractory multiple myeloma patients has been initiated with Aplidin(R) (plitidepsin) in combination with dexamethasone versus dexamethasone alone.
› Verified 6 days ago
| NPI Number | 1811368780 |
| Organization Name | DEPARTMENT OF STATE HOSPITALS-NAPA |
| Address | 2100 Napa Vallejo Hwy., Napa, CA 94558 |
| Hospital Type | Psychiatric Hospital |
| Phone Number | 707-253-5000 |
News Archive
Educating people with diabetes in a primary-care setting with sustained, comprehensive intervention resulted in significant improvement in disease management and overall health, according to a study published in the current issue of Diabetes Care, a journal of the American Diabetes Association (ADA).
Roche Diabetes Care, makers of ACCU-CHEK products and services, has launched dedicated Facebook and Twitter accounts to promote diabetes education, awareness and advocacy.
Emergent BioSolutions Inc. announced today that it has closed on its acquisition of Bracco Diagnostics Inc.'s Healthcare Protective Products Division. This acquisition, which includes the RSDL (decontamination lotion) product that is cleared for marketing by the U.S. Food and Drug Administration for removal or neutralization of chemical warfare agents from the skin, diversifies and broadens Emergent's biodefense franchise into the chemical countermeasure market.
PharmaMar SA today announced that a registration trial in relapsed/refractory multiple myeloma patients has been initiated with Aplidin(R) (plitidepsin) in combination with dexamethasone versus dexamethasone alone.
› Verified 6 days ago
| NPI Number | 1962874172 |
| Organization Name | NAPA STATE HOSPITAL |
| Address | 2100 Napa Vallejo Hwy, Napa, CA 94558 |
| Hospital Type | Psychiatric Hospital |
| Phone Number | 707-815-9690 |
News Archive
Educating people with diabetes in a primary-care setting with sustained, comprehensive intervention resulted in significant improvement in disease management and overall health, according to a study published in the current issue of Diabetes Care, a journal of the American Diabetes Association (ADA).
Roche Diabetes Care, makers of ACCU-CHEK products and services, has launched dedicated Facebook and Twitter accounts to promote diabetes education, awareness and advocacy.
Emergent BioSolutions Inc. announced today that it has closed on its acquisition of Bracco Diagnostics Inc.'s Healthcare Protective Products Division. This acquisition, which includes the RSDL (decontamination lotion) product that is cleared for marketing by the U.S. Food and Drug Administration for removal or neutralization of chemical warfare agents from the skin, diversifies and broadens Emergent's biodefense franchise into the chemical countermeasure market.
PharmaMar SA today announced that a registration trial in relapsed/refractory multiple myeloma patients has been initiated with Aplidin(R) (plitidepsin) in combination with dexamethasone versus dexamethasone alone.
› Verified 6 days ago
News Archive
Educating people with diabetes in a primary-care setting with sustained, comprehensive intervention resulted in significant improvement in disease management and overall health, according to a study published in the current issue of Diabetes Care, a journal of the American Diabetes Association (ADA).
Roche Diabetes Care, makers of ACCU-CHEK products and services, has launched dedicated Facebook and Twitter accounts to promote diabetes education, awareness and advocacy.
Emergent BioSolutions Inc. announced today that it has closed on its acquisition of Bracco Diagnostics Inc.'s Healthcare Protective Products Division. This acquisition, which includes the RSDL (decontamination lotion) product that is cleared for marketing by the U.S. Food and Drug Administration for removal or neutralization of chemical warfare agents from the skin, diversifies and broadens Emergent's biodefense franchise into the chemical countermeasure market.
PharmaMar SA today announced that a registration trial in relapsed/refractory multiple myeloma patients has been initiated with Aplidin(R) (plitidepsin) in combination with dexamethasone versus dexamethasone alone.
› Verified 6 days ago
Queen Of The Valley Medical Center Acute Care Hospital Location: 1000 Trancas St, Napa, California 94558 Phone: (707) 252-4411 | |
Dept Of State Hospitals - Napa Psychiatric Hospital Location: 2100 Napa Vallejo Highway, Napa, California 94558 Phone: (707) 253-5000 |